The company anticipates 2025 revenue to be in the range of $58.0 billion to $61.0 billion, growth of 32% at the midpoint compared to expected 2024 revenue ...

Financial writer cautious on Eli Lilly stock despite strong performance, citing high valuation and underperforming drugs.

Eli Lilly and Company’s LLY shares declined 13.5% in the past three months. Though demand for its popular tirzepatide drugs, ...

FOIA requests to the federal government often are signals. They can be an important early warning of bad publicity, litigation to come, or uncertainties to be hedged and gamed out. When the flow of ...

Investors with a lot of money to spend have taken a bullish stance on Eli Lilly LLY. And retail traders should know. We ...

The drug and biotech industry had a tough time in the past couple of months after Trump announced the appointment of Robert F ...

There's a warning for people looking to buy Mounjaro and Ozempic online or without a prescription, as many look to obtain the weight loss wonder drugs privately, ahead of the long waits for NHS ...

There's a warning for people looking to buy Mounjaro and Ozempic online or without a prescription, as many look to obtain the weight loss wonder drugs privately, ahead of the long waits for NHS weight ...

"Year to date" sales for 2021, 2022, 2023, and 2024 sales are shown in series at the top of the table and then just below a comparison of 2024 versus 2023 and 2024 versus 2022 is displayed. This ...

Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include ...